Hints and tips:
Related Special Reports
...Influencers affiliated with Ogilvy will need to clearly say when they are being paid by a pharma company....
...Pfizer’s chief executive Albert Bourla said on the company’s most recent earnings call that it would have much more clarity and certainty about the future of its Covid products by the end of the year....
...Because the European market is saturated with the BioNTech/Pfizer and Moderna shots, it remains unclear what impact on its revenues an approval might have....
...The Paris-headquartered company said it was “confident” its vaccine remained a “valuable option”....
...Germany-based BioNTech struck a deal with Pfizer to help develop and commercialise Comirnaty and the two companies agreed to split profits....
...The company said the security services were “in the interests of the company and its shareholders”, owing to the “critical value” the pair provided....
...Contributions from the company’s acquisitions — notably the $43bn purchase of cancer biotechnology company Seagen — have yet to move the needle....
...Pfizer shares tumbled more than 8 per cent after the US drugmaker forecast 2024 revenues that were below consensus estimates, as the company attempts to chart a future for growth without blockbuster Covid...
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...Panuwat’s company, Medivation, was bought in 2016 by Pfizer for $14bn. But the stock he purchased at the time was not that of Medivation....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...The company said last year that its oral obesity pills could generate more than $10bn in future revenues....
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
Case studies in best practice among general counsel and company legal teams in North America
...The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US....
...Albert Bourla, Pfizer’s chief executive, said the company’s product portfolio, apart from Covid medicines, remained strong, with the company expecting revenues from the rest of the business to grow between...
...Yet Pfizer’s $19bn in Paxlovid sales were almost a fifth of its 2022 total....
...Roche plans to buy immunology company Telavant from Roivant Sciences and Pfizer for more than $7bn, as the drugmaker’s new chief executive seeks to replenish its drug pipeline....
...In a statement, Pfizer said the alleged conduct was a “violation of the company’s policies” and that it was “co-operating with the government’s investigation”....
...Pfizer on Tuesday raised $31bn in a jumbo-sized bond sale that will help fund the takeover....
...Pfizer is putting its Covid-19 windfall to work by splashing out $43bn to buy cancer biotechnology company Seagen....
...” about the company’s transition from the pandemic emergency....
...Shares in Pfizer added about 1 per cent on Friday, while Seagen was up about 0.9 per cent....
...In 2020, Pfizer spun off its generics business Upjohn, combining it with Mylan to form Viatris, while Johnson & Johnson, GSK, Pfizer and Novartis have all shed their consumer health businesses selling over-the-counter...
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
International Edition